Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764

On page 761, in the first sentence of the Introduction, where it reads: ”Cardiovascular Botulinum toxin A (BoNT-A) has been approved for spasticity management.” It should read: “Botulinum toxin A (BoNT-A) has been approved for spasticity management.” Article published with errors: https://www.acta...

Full description

Bibliographic Details
Main Author: Carla de Sousa
Format: Article
Language:English
Published: Ordem dos Médicos 2020-12-01
Series:Acta Médica Portuguesa
Online Access:https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15226
id doaj-45e7042160a1407aa3ed19e897e8301b
record_format Article
spelling doaj-45e7042160a1407aa3ed19e897e8301b2020-12-02T20:31:20ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07582020-12-01331286086010.20344/amp.152265324Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764Carla de Sousa0Acta Médica Portuguesa. Lisboa.On page 761, in the first sentence of the Introduction, where it reads: ”Cardiovascular Botulinum toxin A (BoNT-A) has been approved for spasticity management.” It should read: “Botulinum toxin A (BoNT-A) has been approved for spasticity management.” Article published with errors: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/11503https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15226
collection DOAJ
language English
format Article
sources DOAJ
author Carla de Sousa
spellingShingle Carla de Sousa
Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764
Acta Médica Portuguesa
author_facet Carla de Sousa
author_sort Carla de Sousa
title Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764
title_short Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764
title_full Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764
title_fullStr Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764
title_full_unstemmed Correction to the article “Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity”, published on Acta Med Port 2020 Nov;33(11):761-764
title_sort correction to the article “contralateral upper limb weakness following botulinum toxin a injection for poststroke spasticity”, published on acta med port 2020 nov;33(11):761-764
publisher Ordem dos Médicos
series Acta Médica Portuguesa
issn 0870-399X
1646-0758
publishDate 2020-12-01
description On page 761, in the first sentence of the Introduction, where it reads: ”Cardiovascular Botulinum toxin A (BoNT-A) has been approved for spasticity management.” It should read: “Botulinum toxin A (BoNT-A) has been approved for spasticity management.” Article published with errors: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/11503
url https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15226
work_keys_str_mv AT carladesousa correctiontothearticlecontralateralupperlimbweaknessfollowingbotulinumtoxinainjectionforpoststrokespasticitypublishedonactamedport2020nov3311761764
_version_ 1724401843995410432